These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2111840)

  • 1. Enhanced killing of group B streptococci in vitro by penicillin and opsonophagocytosis with intravenous immunoglobulin.
    Miller PS; Schauf V; Salo RJ
    J Infect Dis; 1990 Jun; 161(6):1225-30. PubMed ID: 2111840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synergistic action of penicillin and immunoglobulin for intravenous (IVIG) use].
    Bucholc B; Banach W
    Med Dosw Mikrobiol; 1996; 48(3-4):201-10. PubMed ID: 9182143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models.
    Givner LB
    Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High intravenous doses of human immune globulin suppress neonatal group B streptococcal immunity in rats.
    Weisman LE; Lorenzetti PM
    J Pediatr; 1989 Sep; 115(3):445-50. PubMed ID: 2671331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.
    Fischer GW
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococci.
    Fischer GW; Wilson SR; Hunter KW
    J Clin Immunol; 1982 Apr; 2(2 Suppl):31S-35S. PubMed ID: 7045156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired phagocytosis and opsonisation towards group B streptococci in preterm neonates.
    Källman J; Schollin J; Schalèn C; Erlandsson A; Kihlström E
    Arch Dis Child Fetal Neonatal Ed; 1998 Jan; 78(1):F46-50. PubMed ID: 9536841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines enhance opsonophagocytosis of type III group B Streptococcus.
    Campbell JR; Edwards MS
    J Perinatol; 2000 Jun; 20(4):225-30. PubMed ID: 10879334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates.
    Weisman LE; Anthony BF; Hemming VG; Fischer GW
    J Pediatr; 1993 Jun; 122(6):929-37. PubMed ID: 8501574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune globulin for intravenous use: enhancement of in vitro opsonophagocytic activity of neonatal serum.
    Givner LB; Edwards MS; Anderson DC; Baker CJ
    J Infect Dis; 1985 Feb; 151(2):217-20. PubMed ID: 3918123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type III group B streptococcal strain differences in susceptibility to opsonization with human serum.
    Fischer GW; Hunter KW; Wilson SR
    Pediatr Res; 1981 Dec; 15(12):1525-9. PubMed ID: 7033908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.
    Fujieda M; Aoyagi Y; Matsubara K; Takeuchi Y; Fujimaki W; Matsushita M; Bohnsack JF; Takahashi S
    Infect Immun; 2012 Jun; 80(6):2053-60. PubMed ID: 22451515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsonic effect of jacalin and human immunoglobulin A on type II group B streptococci.
    Payne NR; Concepcion NF; Anthony BF
    Infect Immun; 1990 Nov; 58(11):3663-70. PubMed ID: 2228238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsonic activity of commercially available standard intravenous immunoglobulin preparations.
    Weisman LE; Cruess DF; Fischer GW
    Pediatr Infect Dis J; 1994 Dec; 13(12):1122-5. PubMed ID: 7892082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human IgG 3 is opsonic in vitro against type III group B streptococci.
    Kim JS; Kim KS; Wass CA; Short JA; Heiner DC
    J Clin Immunol; 1990 May; 10(3):154-9. PubMed ID: 2195055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of complement receptors in opsonophagocytosis of group B streptococci by adult and neonatal neutrophils.
    Smith CL; Baker CJ; Anderson DC; Edwards MS
    J Infect Dis; 1990 Aug; 162(2):489-95. PubMed ID: 2197341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-related protective efficacy of immunoglobulins in experimentally induced group B streptococcal infection.
    Iguchi K; Inoue S
    Acta Paediatr Jpn; 1994 Feb; 36(1):25-9. PubMed ID: 8165904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy.
    Yang KD; Bathras JM; Shigeoka AO; James J; Pincus SH; Hill HR
    J Infect Dis; 1989 Apr; 159(4):701-7. PubMed ID: 2494269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci.
    Albanyan EA; Edwards MS
    Infect Immun; 2000 Oct; 68(10):5794-802. PubMed ID: 10992487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A polyclonal human IgG preparation hyperimmune for type III, group B Streptococcus: in vitro opsonophagocytic activity and efficacy in experimental models.
    Givner LB; Edwards MS; Baker CJ
    J Infect Dis; 1988 Oct; 158(4):724-30. PubMed ID: 3049837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.